Cyclerion Therapeutics CYCN Q1 2026 Annual earnings
Reported May 12, 2026 · After market close
EPS estimate-$17.20
Next report
Aug 4, 2026 (In 3 weeks)Revenue estimate$1.5M
EPS estimate-$7.10
Versus estimates
Diluted EPS
Q1 2026-$0.76Beat by $16.44
Q4 2025-$0.19Beat by $0.19Q1 2024-$0.38In lineQ3 2025-$0.30Q2 2025-$0.11Q1 2025-$0.56Ask the moment Cyclerion Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Cyclerion Therapeutics report Q1 2026 earnings?
- Cyclerion Therapeutics (CYCN) reported Q1 2026 earnings on May 12, 2026 after market close.
- What were Cyclerion Therapeutics's Q1 2026 revenue and EPS?
- Cyclerion Therapeutics reported diluted EPS of $-0.76 for Q1 2026.
- Did Cyclerion Therapeutics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-17.20 by $16.44.
- How did Cyclerion Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 35.7% from $-0.56.
- Where can I find Cyclerion Therapeutics's Q1 2026 SEC filings?
- You can read the 10-K/A periodic report (0001193125-26-194204) directly on SEC EDGAR. The filing index links above go to sec.gov.